1. Home
  2. AYTU vs LITB Comparison

AYTU vs LITB Comparison

Compare AYTU & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • LITB
  • Stock Information
  • Founded
  • AYTU N/A
  • LITB 2007
  • Country
  • AYTU United States
  • LITB Singapore
  • Employees
  • AYTU N/A
  • LITB N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • AYTU Health Care
  • LITB Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • LITB Nasdaq
  • Market Cap
  • AYTU 19.7M
  • LITB 21.1M
  • IPO Year
  • AYTU N/A
  • LITB N/A
  • Fundamental
  • Price
  • AYTU $2.20
  • LITB $1.24
  • Analyst Decision
  • AYTU Strong Buy
  • LITB
  • Analyst Count
  • AYTU 2
  • LITB 0
  • Target Price
  • AYTU $10.00
  • LITB N/A
  • AVG Volume (30 Days)
  • AYTU 109.6K
  • LITB 12.6K
  • Earning Date
  • AYTU 09-25-2025
  • LITB 09-02-2025
  • Dividend Yield
  • AYTU N/A
  • LITB N/A
  • EPS Growth
  • AYTU N/A
  • LITB N/A
  • EPS
  • AYTU N/A
  • LITB 0.08
  • Revenue
  • AYTU $81,659,000.00
  • LITB $231,136,000.00
  • Revenue This Year
  • AYTU N/A
  • LITB N/A
  • Revenue Next Year
  • AYTU $1.05
  • LITB N/A
  • P/E Ratio
  • AYTU N/A
  • LITB $15.73
  • Revenue Growth
  • AYTU 0.41
  • LITB N/A
  • 52 Week Low
  • AYTU $0.95
  • LITB $0.91
  • 52 Week High
  • AYTU $2.85
  • LITB $4.80
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 43.54
  • LITB 47.45
  • Support Level
  • AYTU $2.15
  • LITB $1.15
  • Resistance Level
  • AYTU $2.28
  • LITB $1.33
  • Average True Range (ATR)
  • AYTU 0.11
  • LITB 0.10
  • MACD
  • AYTU -0.03
  • LITB -0.01
  • Stochastic Oscillator
  • AYTU 16.07
  • LITB 33.33

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: